Who Owns GALMED PHARMACEUTICALS (GLMD)? -- Institutional Holders (2026-06-30)

18 institutions reported holding $85,901 of GALMED PHARMACEUTICALS (GLMD) in SEC 13F filings for 2026-06-30. Largest institutional holders: CITADEL ADVISORS LLC ($48,315), HRT FINANCIAL LP ($23,000), XTX Topco Ltd ($8,353), TWO SIGMA SECURITIES, LLC ($6,126), SBI Securities Co., Ltd. ($37). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1CITADEL ADVISORS LLC$48,31586,851Added
2HRT FINANCIAL LP$23,00042,090New
3XTX Topco Ltd$8,35315,015Trimmed
4TWO SIGMA SECURITIES, LLC$6,12611,012Trimmed
5SBI Securities Co., Ltd.$3766Added
6MORGAN STANLEY$3156Trimmed
7WELLS FARGO & COMPANY/MN$2443Hold
8Federation des caisses Desjardins du Quebec$814Hold
9Allworth Financial LP$22Hold
10UBS Group AG$23Trimmed
11OSAIC HOLDINGS, INC.$25Hold
12ELEVATION WEALTH PARTNERS, LLC$11Hold
13Royal Bank of Canada$0550New
14BNP PARIBAS FINANCIAL MARKETS$00Exited
15TWO SIGMA INVESTMENTS, LP$00Exited
16JANE STREET GROUP, LLC$00Exited
17TSFG, LLC$017Hold
18Dogwood Wealth Management LLC$00Exited

Source: SEC Form 13F filings · as of 2026-06-30